Clinical Trials · NCT02730104
Community-based Neuroendocrine Tumor (NET) Research Study
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Ipsen
- Enrollment
- 100
- Start date
- Nov 2015
- Locations
- 12 sites, United States
- Primary endpoint
- Time to disease progression